Developer docs
API playgroundTry for free, no card

Search company profiles

Centre for Genomic Regulation

Full company profile

uuid00071hf

Namestring
Centre for Genomic Regulation
Legal namestring
FUNDACIO CENTRE DE REGULACIO GENOMICA
Websiteurl
crg.eu
Company typeenum
Private
Founded yearint
2000
Descriptiontext

The Centre for Genomic Regulation (CRG) is a Spanish non-profit biomedical research institute founded in 2000 and headquartered at the Barcelona Biomedical Research Park (PRBB). It operates four research programmes spanning bioinformatics, genome biology, cell and tissue biology, and gene regulation/stem cells/cancer, supported by a Core Technologies Programme offering genomics, proteomics, bioinformatics, advanced light microscopy, flow cytometry, and tissue engineering services. CRG produces proprietary computational tools (Geneid, AStalavista, CRISPETa, GEMtools, U12DB, Selenoprofiles, the Lifespan Machine), the Single Cell Genomics Platform for massively parallel cellular profiling, and the European Genome-Phenome Archive for secure cross-border human genetic data sharing.

The institute's commercial surface is intentionally non-monetised: CRG follows an Open Science policy (in force since April 2016) and derives its budget almost entirely from public research grants and institutional contributions from the Generalitat de Catalunya, Ministerio de Ciencia e Innovación, Universitat Pompeu Fabra, and "la Caixa" Foundation, supplemented by EU framework programme awards (Horizon 2020, ERC, EIC) and member consortium dues from BIST, SOMMa, ELIXIR, EuroBioImaging, and ISBE. Recent grant wins include €19.3M PrecisionTox, €10M ERC Synergy, €5M SYSAGING, and a record fourth ERC Advanced Grant to Luis Serrano.

Its customer base is the global scientific community served via open access publications, open-source software, training programmes for PhD students and postdoctoral researchers, and the Barcelona Collaboratorium. The institute operates a Technology and Business Development Office (TBDO) for IP transfer. Employing 501-1000 staff with Severo Ochoa excellence accreditation and HR Excellence in Research certification, CRG is positioned as a translational research platform rather than a commercial entity.

Short descriptiontext

The Centre for Genomic Regulation (CRG) is a Barcelona-based international biomedical research institute of excellence, producing open-access genomic and computational biology research, AI/ML models, and core technology services for the global scientific community, funded primarily by public research grants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research, genomic analysis, computational biology, single-cell genomics, life sciences training
Industry2 codes
1Clinical Data Management, Biostatistics & Statistical Programming CROs
CodeHLAGAAAFPrimaryYes
2Central Laboratory & Clinical Trial Testing CROs
CodeHLAGAAAEPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Public Research Funding
TypeSubscription Recurring
Description

CRG is a publicly funded research institute receiving support from government agencies including Generalitat de Catalunya, Ministerio de Ciencia e Innovación, European Union funds, and international funding bodies. The institute has a track record of securing prestigious international public and private funding.

crg.eu
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence that conducts fundamental and translational research in genomics, cell biology, and disease mechanisms. It provides shared scientific infrastructure (genomics, proteomics, bioinformatics, advanced imaging), develops open-source computational biology tools, manages the European Genome-Phenome Archive for human genetic data, and trains PhD students and postdoctoral researchers. Its output is disseminated through open access publications, research collaborations, and participation in pan-European research infrastructures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Roderic Guigó elected to EMBO Membership
+2 more records
Product overview1 text field

Centre for Genomic Regulation (CRG) is an international biomedical research institute offering a portfolio of research technologies, computational tools, and collaborative platforms. The core offerings include: (1) the Core Technologies Programme providing shared scientific infrastructure for genomics, proteomics, bioinformatics, and advanced imaging; (2) the European Genome-Phenome Archive (EGA) for secure human genetic data storage and sharing; (3) specialized software tools from research labs including AStalavista, Geneid, CRISPETa, and GEMtools; (4) Single Cell Genomics Platform for cellular-level genomic analysis; (5) AI/ML models including popEVE for rare disease diagnosis; and (6) the Barcelona Collaboratorium for interdisciplinary research collaboration.

Product and service9 records
1Core Technologies Programme
CategoryScientific Services / Core Facility
Description

Shared scientific infrastructure providing access to advanced research technologies including genomics, proteomics, bioinformatics, advanced light microscopy, flow cytometry, and tissue engineering services for researchers and scientific collaborators.

2European Genome-Phenome Archive (EGA)
CategoryData Resource / Repository
Description

European archive service for securely storing and sharing human genetic and phenome data, enabling cross-border genomic data sharing for biomedical researchers.

3Single Cell Genomics Platform
CategoryResearch Technology Platform
Description

Transversal research platform providing single-cell level genomic analysis to study cellular heterogeneity in tissues and organisms, used in cancer research, stem cell biology, and gene regulation studies.

4Guigó Lab Computational Biology Tools
CategoryResearch Software / Open-Source Tools
Description

Suite of open-source computational tools including AStalavista for alternative splicing analysis, Geneid for ab initio gene prediction, CRISPETa for CRISPR sgRNA design, GEMtools for sequence mapping, and gff2ps for genomic annotation visualization, made available to the research community.

5popEVE
CategoryAI/ML Model
Description

Deep generative AI model developed with Harvard Medical School that estimates deleteriousness of genetic variants across the proteome using evolutionary principles, supporting rare disease diagnosis.

6Barcelona Collaboratorium
CategoryResearch Collaboration Platform
Description

Collaborative platform combining scientific excellence with integration of early-career researchers through discussion sessions, networking, and community-building activities.

7Research Training Programmes
CategoryEducation and Training
Description

Structured educational programmes for undergraduates, masters, PhD students, and postdoctoral researchers seeking training in genomics, cell biology, computational biology, and related life sciences disciplines.

8Neuroscience Resources
CategoryScientific Resources
Description

Scientific resources and tools supporting neuroscience research at CRG and provided to the broader research community.

9PRBB μFabLab
CategoryScientific Infrastructure
Description

Microfabrication laboratory providing nanofabrication and prototyping capabilities to researchers across the Barcelona Biomedical Research Park (PRBB) and affiliated institutions.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
1Shenzhen Institutes of Advanced Technology (SMART) and Shenzhen Bay Laboratory (SZBL)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-30
Description

MoU signed to bring Barcelona science closer to the Guangdong-Hong Kong-Macao Greater Bay Area, fostering international research collaboration.

crg.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Board of Trustees member providing institutional governance and support to CRG as part of the CERCA system of research institutes in Catalonia.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spanish Ministry of Science and Innovation as Board of Trustees member, providing national-level governance and funding support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UPF as founding university partner and Board of Trustees member, providing academic affiliation and collaborative research opportunities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

"la Caixa" Foundation as Board of Trustees member supporting biomedical research through funding and institutional collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRG is a member of BIST, a consortium of cutting-edge Barcelona research centers working on interdisciplinary science.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance of Severo Ochoa and María de Maeztu Excellence Centers, organizing events like SOMMa Connect.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CRG is located in and is a member of PRBB, sharing infrastructure with other biomedical research institutions.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

European research infrastructure network for life sciences contributing to collaborative projects and knowledge sharing.

10Core for Life
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Alliance of European life science research centers facilitating collaborative research and technology sharing.

crg.eu
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Spanish biotechnology association connecting research institutions with industry for innovation transfer.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

European Molecular Biology Laboratory Barcelona location, with James Sharpe (former CRG group leader) as Director.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

BIST Ignite Grant collaboration to explore new ways of treating brain disorders using RNA technology.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration to develop AID system for precise protein level control in C. elegans model organism for aging research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

European research infrastructure for life science data, with CRG participating in ELIXIR-CONVERGE and other data-related projects.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

European research infrastructure for imaging technologies where CRG contributes imaging expertise and facilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Infrastructure for systems biology enabling CRG participation in pan-European systems biology networks.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Barcelona-based research institute collaboration including Toni Gabaldón affiliation and Barcelona-wide single cell data club.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

National Center for Genomic Analysis working with CRG on Barcelona-wide single cell data club and joint research.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Supercomputing resources collaboration with Toni Gabaldón affiliated at BSC-CNS for computational genomics.

21EduCaixa
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Educational foundation partner for citizen science project 'Stick your tongue out' studying mouth microbiome.

crg.eu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1European Molecular Biology Laboratory (EMBL)
TypeDirect peer
Description

Intergovernmental molecular biology research institute with comparable scope across genomics, bioinformatics, structural biology and training. EMBL is the most structurally analogous peer to CRG within Europe and competes with it for talent and EU funding.

TypeDirect peer
Description

UK-based genomics research institute with strong overlap in genome analysis, single-cell genomics, computational biology and disease-focused programs at similar headcount and funding scale.

TypeDirect peer
Description

Major US biomedical and genomic research organization with parallel emphasis on computational biology, variant interpretation (e.g., gnomAD-like resources), single-cell analysis and AI for biology.

TypeDirect peer
Description

Barcelona-based biomedical research institute focused on molecular biology and disease mechanisms; shares location, BIST membership, and overlapping faculty collaboration (e.g., Toni Gabaldón).

TypeDirect peer
Description

National genomic analysis centre co-located with CRG at the Barcelona Biomedical Research Park; sister organisation with overlapping large-scale sequencing, single-cell, and data infrastructure activities.

TypeDirect peer
Description

German publicly-funded institute focused on genomics, gene regulation and computational biology — closely comparable research portfolio, public-funding model, and European institutional positioning.

TypeBroad incumbent
Description

Large French foundation-based biomedical research institute with comparable mix of fundamental research, training, and public funding, though broader disease scope than CRG.

TypeDirect peer
Description

MIT-affiliated non-profit biomedical research institute of similar headcount focused on fundamental genomics, stem cells and disease biology — close analog in mission, scale and non-profit research model.

TypeBroad incumbent
Description

Large-scale German publicly-funded life sciences institute under the Helmholtz Association with similar research-grant-driven operating model, broader infectious-disease scope.

TypeDirect peer
Description

EMBL's bioinformatics hub at Hinxton; close peer for CRG's bioinformatics programme, ELIXIR hosting role, and population-scale genomic data resources (similar data-infrastructure mandate).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability14 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centre for Genomic Regulation

Biomedical Research Servicescrg.eu

The Centre for Genomic Regulation (CRG) is a Barcelona-based international biomedical research institute of excellence, producing open-access genomic and computational biology research, AI/ML models, and core technology services for the global scientific community, funded primarily by public research grants.

What Centre for Genomic Regulation does

The Centre for Genomic Regulation (CRG) is a Spanish non-profit biomedical research institute founded in 2000 and headquartered at the Barcelona Biomedical Research Park (PRBB). It operates four research programmes spanning bioinformatics, genome biology, cell and tissue biology, and gene regulation/stem cells/cancer, supported by a Core Technologies Programme offering genomics, proteomics, bioinformatics, advanced light microscopy, flow cytometry, and tissue engineering services. CRG produces proprietary computational tools (Geneid, AStalavista, CRISPETa, GEMtools, U12DB, Selenoprofiles, the Lifespan Machine), the Single Cell Genomics Platform for massively parallel cellular profiling, and the European Genome-Phenome Archive for secure cross-border human genetic data sharing.

The institute's commercial surface is intentionally non-monetised: CRG follows an Open Science policy (in force since April 2016) and derives its budget almost entirely from public research grants and institutional contributions from the Generalitat de Catalunya, Ministerio de Ciencia e Innovación, Universitat Pompeu Fabra, and "la Caixa" Foundation, supplemented by EU framework programme awards (Horizon 2020, ERC, EIC) and member consortium dues from BIST, SOMMa, ELIXIR, EuroBioImaging, and ISBE. Recent grant wins include €19.3M PrecisionTox, €10M ERC Synergy, €5M SYSAGING, and a record fourth ERC Advanced Grant to Luis Serrano.

Its customer base is the global scientific community served via open access publications, open-source software, training programmes for PhD students and postdoctoral researchers, and the Barcelona Collaboratorium. The institute operates a Technology and Business Development Office (TBDO) for IP transfer. Employing 501-1000 staff with Severo Ochoa excellence accreditation and HR Excellence in Research certification, CRG is positioned as a translational research platform rather than a commercial entity.

Centre for Genomic Regulation firmographics

Firmographics
Name
Centre for Genomic Regulation
Legal name
FUNDACIO CENTRE DE REGULACIO GENOMICA
Website
https://crg.eu
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
501–1,000 employees
Short description
The Centre for Genomic Regulation (CRG) is a Barcelona-based international biomedical research institute of excellence, producing open-access genomic and computational biology research, AI/ML models, and core technology services for the global scientific community, funded primarily by public research grants.
Ownership category
akta.pro rank

Centre for Genomic Regulation industry classification

Industry
Product category
Biomedical Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
akta.pro secondary industry
Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

  • Biomedical research
  • Genomic analysis
  • Computational biology
  • Single-cell genomics
  • Life sciences training

Where Centre for Genomic Regulation is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

Centre for Genomic Regulation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

  1. Public Research Funding: CRG is a publicly funded research institute receiving support from government agencies including Generalitat de Catalunya, Ministerio de Ciencia e Innovación, European Union funds, and international funding bodies. The institute has a track record of securing prestigious international public and private funding.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Centre for Genomic Regulation product offering

Product offering

Core offering

Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence that conducts fundamental and translational research in genomics, cell biology, and disease mechanisms. It provides shared scientific infrastructure (genomics, proteomics, bioinformatics, advanced imaging), develops open-source computational biology tools, manages the European Genome-Phenome Archive for human genetic data, and trains PhD students and postdoctoral researchers. Its output is disseminated through open access publications, research collaborations, and participation in pan-European research infrastructures.

Product overview

Centre for Genomic Regulation (CRG) is an international biomedical research institute offering a portfolio of research technologies, computational tools, and collaborative platforms. The core offerings include: (1) the Core Technologies Programme providing shared scientific infrastructure for genomics, proteomics, bioinformatics, and advanced imaging; (2) the European Genome-Phenome Archive (EGA) for secure human genetic data storage and sharing; (3) specialized software tools from research labs including AStalavista, Geneid, CRISPETa, and GEMtools; (4) Single Cell Genomics Platform for cellular-level genomic analysis; (5) AI/ML models including popEVE for rare disease diagnosis; and (6) the Barcelona Collaboratorium for interdisciplinary research collaboration.

Differentiator

Problem solved

Functional benefit

Products and services

  • Core Technologies Programme Shared scientific infrastructure providing access to advanced research technologies including genomics, proteomics, bioinformatics, advanced light microscopy, flow cytometry, and tissue engineering services for researchers and scientific collaborators.
  • European Genome-Phenome Archive (EGA) European archive service for securely storing and sharing human genetic and phenome data, enabling cross-border genomic data sharing for biomedical researchers.
  • Single Cell Genomics Platform Transversal research platform providing single-cell level genomic analysis to study cellular heterogeneity in tissues and organisms, used in cancer research, stem cell biology, and gene regulation studies.
  • Guigó Lab Computational Biology Tools Suite of open-source computational tools including AStalavista for alternative splicing analysis, Geneid for ab initio gene prediction, CRISPETa for CRISPR sgRNA design, GEMtools for sequence mapping, and gff2ps for genomic annotation visualization, made available to the research community.
  • popEVE Deep generative AI model developed with Harvard Medical School that estimates deleteriousness of genetic variants across the proteome using evolutionary principles, supporting rare disease diagnosis.
  • Barcelona Collaboratorium Collaborative platform combining scientific excellence with integration of early-career researchers through discussion sessions, networking, and community-building activities.
  • Research Training Programmes Structured educational programmes for undergraduates, masters, PhD students, and postdoctoral researchers seeking training in genomics, cell biology, computational biology, and related life sciences disciplines.
  • Neuroscience Resources Scientific resources and tools supporting neuroscience research at CRG and provided to the broader research community.
  • PRBB μFabLab Microfabrication laboratory providing nanofabrication and prototyping capabilities to researchers across the Barcelona Biomedical Research Park (PRBB) and affiliated institutions.

Quantifiable outcome

  • Roderic Guigó elected to EMBO Membership
  • +2 more outcomes

Companies that use Centre for Genomic Regulation

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Centre for Genomic Regulation technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability14 records

Feature11 records

Centre for Genomic Regulation partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered major, core and minor.

  • Shenzhen Institutes of Advanced Technology (SMART) and Shenzhen Bay Laboratory (SZBL)majorStrategic or Co-development Partner · 30 June 2026MoU signed to bring Barcelona science closer to the Guangdong-Hong Kong-Macao Greater Bay Area, fostering international research collaboration.
  • Generalitat de CatalunyacoreStrategic or Co-development PartnerBoard of Trustees member providing institutional governance and support to CRG as part of the CERCA system of research institutes in Catalonia.
  • Ministerio de Ciencia e InnovacióncoreStrategic or Co-development PartnerSpanish Ministry of Science and Innovation as Board of Trustees member, providing national-level governance and funding support.
  • Universitat Pompeu FabracoreStrategic or Co-development PartnerUPF as founding university partner and Board of Trustees member, providing academic affiliation and collaborative research opportunities.
  • "la Caixa" FoundationcoreStrategic or Co-development Partner"la Caixa" Foundation as Board of Trustees member supporting biomedical research through funding and institutional collaboration.
  • Barcelona Institute of Science and Technology (BIST)coreStrategic or Co-development PartnerCRG is a member of BIST, a consortium of cutting-edge Barcelona research centers working on interdisciplinary science.
  • SOMMacoreStrategic or Co-development PartnerAlliance of Severo Ochoa and María de Maeztu Excellence Centers, organizing events like SOMMa Connect.
  • Barcelona Biomedical Research Park (PRBB)coreStrategic or Co-development PartnerCRG is located in and is a member of PRBB, sharing infrastructure with other biomedical research institutions.
  • EU LifemajorStrategic or Co-development PartnerEuropean research infrastructure network for life sciences contributing to collaborative projects and knowledge sharing.
  • Core for LifemajorStrategic or Co-development PartnerAlliance of European life science research centers facilitating collaborative research and technology sharing.
  • AseBiominorStrategic or Co-development PartnerSpanish biotechnology association connecting research institutions with industry for innovation transfer.
  • EMBL BarcelonamajorStrategic or Co-development PartnerEuropean Molecular Biology Laboratory Barcelona location, with James Sharpe (former CRG group leader) as Director.
  • Institute for Bioengineering of Catalonia (IBEC)majorStrategic or Co-development PartnerBIST Ignite Grant collaboration to explore new ways of treating brain disorders using RNA technology.
  • University of CambridgemajorStrategic or Co-development PartnerCollaboration to develop AID system for precise protein level control in C. elegans model organism for aging research.
  • ELIXIRcoreStrategic or Co-development PartnerEuropean research infrastructure for life science data, with CRG participating in ELIXIR-CONVERGE and other data-related projects.
  • EuroBioImagingcoreStrategic or Co-development PartnerEuropean research infrastructure for imaging technologies where CRG contributes imaging expertise and facilities.
  • ISBEcoreStrategic or Co-development PartnerInfrastructure for systems biology enabling CRG participation in pan-European systems biology networks.
  • IRB BarcelonamajorStrategic or Co-development PartnerBarcelona-based research institute collaboration including Toni Gabaldón affiliation and Barcelona-wide single cell data club.
  • CNAG-CRGmajorStrategic or Co-development PartnerNational Center for Genomic Analysis working with CRG on Barcelona-wide single cell data club and joint research.
  • Barcelona Supercomputing Center (BSC-CNS)majorStrategic or Co-development PartnerSupercomputing resources collaboration with Toni Gabaldón affiliated at BSC-CNS for computational genomics.
  • EduCaixaminorStrategic or Co-development PartnerEducational foundation partner for citizen science project 'Stick your tongue out' studying mouth microbiome.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Centre for Genomic Regulation competitors and assessment

Company assessment

Direct peers

  • European Molecular Biology Laboratory (EMBL): Intergovernmental molecular biology research institute with comparable scope across genomics, bioinformatics, structural biology and training. EMBL is the most structurally analogous peer to CRG within Europe and competes with it for talent and EU funding.
  • Wellcome Sanger Institute: UK-based genomics research institute with strong overlap in genome analysis, single-cell genomics, computational biology and disease-focused programs at similar headcount and funding scale.
  • Broad Institute of MIT and Harvard: Major US biomedical and genomic research organization with parallel emphasis on computational biology, variant interpretation (e.g., gnomAD-like resources), single-cell analysis and AI for biology.
  • Institute for Research in Biomedicine (IRB Barcelona): Barcelona-based biomedical research institute focused on molecular biology and disease mechanisms; shares location, BIST membership, and overlapping faculty collaboration (e.g., Toni Gabaldón).
  • Centro Nacional de Análisis Genómico (CNAG-CRG): National genomic analysis centre co-located with CRG at the Barcelona Biomedical Research Park; sister organisation with overlapping large-scale sequencing, single-cell, and data infrastructure activities.
  • Max Planck Institute for Molecular Genetics: German publicly-funded institute focused on genomics, gene regulation and computational biology — closely comparable research portfolio, public-funding model, and European institutional positioning.
  • Whitehead Institute for Biomedical Research: MIT-affiliated non-profit biomedical research institute of similar headcount focused on fundamental genomics, stem cells and disease biology — close analog in mission, scale and non-profit research model.
  • European Bioinformatics Institute (EMBL-EBI): EMBL's bioinformatics hub at Hinxton; close peer for CRG's bioinformatics programme, ELIXIR hosting role, and population-scale genomic data resources (similar data-infrastructure mandate).

Broad incumbents

  • Institut Pasteur: Large French foundation-based biomedical research institute with comparable mix of fundamental research, training, and public funding, though broader disease scope than CRG.
  • Helmholtz Centre for Infection Research (HZI): Large-scale German publicly-funded life sciences institute under the Helmholtz Association with similar research-grant-driven operating model, broader infectious-disease scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Centre for Genomic Regulation social profiles

Digital presence

Centre for Genomic Regulation compliance and trust

Trust signal

Compliance2 records

Centre for Genomic Regulation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centre for Genomic Regulation leadership team

Management profile

Number of profiles

Profiles7 records

Centre for Genomic Regulation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centre for Genomic Regulation M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre for Genomic Regulation

What does Centre for Genomic Regulation do?

Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence that conducts fundamental and translational research in genomics, cell biology, and disease mechanisms. It provides shared scientific infrastructure (genomics, proteomics, bioinformatics, advanced imaging), develops open-source computational biology tools, manages the European Genome-Phenome Archive for human genetic data, and trains PhD students and postdoctoral researchers. Its output is disseminated through open access publications, research collaborations, and participation in pan-European research infrastructures.

Is Centre for Genomic Regulation a public or private company?

Centre for Genomic Regulation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Centre for Genomic Regulation founded?

Centre for Genomic Regulation was founded in 2000. It employs 501 to 1,000 people.

Where is Centre for Genomic Regulation based?

Centre for Genomic Regulation is headquartered in Barcelona, Spain, in the Europe region.

How does Centre for Genomic Regulation make money?

One revenue line is on record: public Research Funding.

Who are Centre for Genomic Regulation's main competitors?

Direct peers on record are European Molecular Biology Laboratory (EMBL), Wellcome Sanger Institute, Broad Institute of MIT and Harvard, Institute for Research in Biomedicine (IRB Barcelona), Centro Nacional de Análisis Genómico (CNAG-CRG), Max Planck Institute for Molecular Genetics, Whitehead Institute for Biomedical Research and European Bioinformatics Institute (EMBL-EBI). Broad incumbents are Institut Pasteur and Helmholtz Centre for Infection Research (HZI).

Does Centre for Genomic Regulation have an API?

No public API is recorded for Centre for Genomic Regulation.

What industry is Centre for Genomic Regulation in?

Centre for Genomic Regulation's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AsabysALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of AsabysALLOX, a spin-off from the Centre for Genomic Regulation, was incorporated and closed an undisclosed pre-seed round from Asabys' Sabadell Asabys II fund. The company develops a platform to map allosteric sites in proteins for drug discovery. It plans a new financial round in 18-24 months.SciTechDailyCould This Cellular “Cleanup Crew” Hold New Clues to Chronic Inflammation?Researchers at the Center for Genomic Regulation in Barcelona discovered that epithelial cells repurpose E-cadherin adhesion machinery to engulf dying cells while keeping tissue sealed. The study, published in Nature Communications, shows the mechanism works in zebrafish and mouse embryos, and may help explain chronic inflammation from failed cleanup.News-MedicalCellular glue protein found to help clear away dead cellsResearchers at the Centre for Genomic Regulation in Barcelona found that the E-cadherin adhesion complex, which holds epithelial cells together, also enables those cells to engulf dying cells. Published in Nature Communications, the study used zebrafish and mouse embryos and showed the mechanism is shared across vertebrates. The team said the finding may help explain chronic inflammation when clearance fails.Mirage NewsTissue Glue Aids in Swallowing Dead CellsResearchers at the Centre for Genomic Regulation in Barcelona found that the E-cadherin protein complex, which normally holds epithelial cells together, also enables those cells to engulf nearby dead cells. Published in Nature Communications, the study used zebrafish and mouse embryos and identified a tethering protein and a contractile "brake" required for clearance. The team said the mechanism may apply to adult tissues, where unremoved dying cells cause chronic inflammation.Mirage News3D Ovary Map Shows Mice Count Their Own EggsA new study published in Nature Ageing reveals that the ovary of mice possesses a mechanism that regulates the activation of egg cells, maintaining a consistent activation rate throughout their lifespan. Researchers at the Centre for Genomic Regulation in Barcelona created a comprehensive three-dimensional map of mouse ovaries, tracking over 85,000 cells to uncover significant insights about ovarian function and egg activation dynamics. The findings suggest potential implications for understanding reproductive health and delaying menopause in humans.The Brighter Side of NewsScientists discover 2-billion-year-old rules that control genes across all life forms on EarthResearchers from the Centre for Genomic Regulation in Barcelona discovered that cells across diverse life forms share ancient, conserved mechanisms for activating genes, likely originating 2 billion years ago. The study utilized a new multiplexed chromatin profiling method called iChIP2 to compare histone modifications across 12 distinct species, revealing that gene silencing strategies evolved differently among various branches of life. These findings provide insights into genome regulation and disease mechanisms, particularly regarding faulty chromatin control linked to conditions like cancer.GenengnewsEvolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off DynamicallyResearchers at the Centre for Genomic Regulation (CRG) and Barcelona Institute of Science and Technology (BIST) found that signals for gene activation have remained nearly unchanged across two billion years of evolution, while gene-silencing mechanisms vary dramatically between different branches of life. The study, published in Nature Genetics, analyzed chromatin regulation across twelve phylogenetically diverse species using a new method called iChIP2. The findings could inform medical research into diseases involving faulty gene regulation, including cancers, and support broader efforts like the Earth BioGenome Project to understand genome function across life on Earth.News-MedicalCells share universal on switches but evolve unique strategy to silence genesResearchers at the Centre for Genomic Regulation in Barcelona conducted the broadest comparative study to date of how different life forms regulate their genomes, analyzing chromatin across twelve phylogenetically diverse species. The study, published in Nature Genetics, found that the signals cells use to activate genes have remained nearly unchanged across approximately two billion years of evolution, while the mechanisms for silencing genes vary dramatically across different branches of life. The researchers developed a new method called iChIP2 that enabled them to profile twelve histone modifications across species ranging from amoebae to sea anemones, revealing that different lineages have evolved distinct molecular toolkits to silence genes and parasitic DNA elements like transposable elements.Mirage NewsLife's Universal Language Activates, Silences GenesResearchers at the Centre for Genomic Regulation in Barcelona conducted the largest comparative analysis to date of how different life forms regulate their genomes through chromatin, finding that the molecular signals for gene activation have remained nearly unchanged across approximately two billion years of evolution, while gene silencing mechanisms vary dramatically between different branches of life. The study, published in Nature Genetics, developed a new method called iChIP2 that enabled profiling of twelve histone modifications across twelve phylogenetically diverse species, revealing that different lineages evolved distinct molecular strategies to silence genes and parasitic DNA elements like transposable elements. The findings could have implications for understanding diseases involving faulty gene regulation, including cancers, and support international genomic efforts such as the Earth BioGenome Project.Mirage NewsKey Genetic Fragments Signal Brain Rest TimeAn international study led by Pompeu Fabra University and the Centre for Genomic Regulation found that altered microexons in zebrafish neurons cause hyperarousal, characterized by heightened neural activity, reduced sleep, and sensory hypersensitivity. The researchers discovered that mis-splicing of these genetic fragments disrupts cAMP levels, which acts as a regulator of neuronal activity, and demonstrated that this hyperactivity can be normalized by pharmacologically manipulating cAMP. The findings, published in Science Advances, suggest this mechanism may be conserved in mammals and could provide insights into neurodevelopmental disorders such as autism and schizophrenia.